Mark J Smyth

21PUBLICATIONS
37CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Haematological tumoursPeripheral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 26, 2020
The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation.

Susanna S Ng, Fabian De Labastida Rivera, Juming Yan

|Aug 14, 2020
Targeting immune checkpoints in hematological malignancies.

Basit Salik, Mark J Smyth, Kyohei Nakamura

|Aug 05, 2020
Systemic administration of IL-33 induces a population of circulating KLRG1hi type 2 innate lymphoid cells and inhibits type 1 innate immunity against multiple myeloma.

Camille Guillerey, Kimberley Stannard, Jason Chen

|Jul 31, 2020
Targeting CD39 in cancer.

Achim K Moesta, Xian-Yang Li, Mark J Smyth

|Jul 22, 2020
The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies.

Tobias Bald, Matthew F Krummel, Mark J Smyth

|Jun 15, 2020
Cancer-killing, decoy-resistant interleukin-18.

Kyohei Nakamura, Tobias Bald, Mark J Smyth

Pageof 4

Frequent Collaborators

6 joint publications

Kyohei Nakamura

4 joint publications

Tobias Bald

3 joint publications

Camille Guillerey

3 joint publications

Susanna S Ng